The global intravascular ultrasound systems market size is worth US$ 772 Mn in 2022. The market is projected to witness a robust CAGR of 5% over the forecast period to arrive at a market valuation of US$ 1,257.51 Mn by 2032. The rapid growth of the market over the coming years can be attributed to the significant rise in the number of percutaneous coronary interventions and stent procedures.
The market for intravascular ultrasound systems is being catalyzed by the growing research and development activities by med-tech companies to formulate hybrid catheters utilizing IVUS and OCT imaging modalities to make progression in the diagnosis of multi-vessel coronary artery disease. Additionally, the growing requirement for results exhibiting superior and precise medical imaging is providing sufficient stimulus to the formulation of digital and advanced ultrasound devices consolidated with Artificial Intelligence (AI).
In March 2021, GE Healthcare, a leading provider of radiopharmaceuticals and diagnostic imaging agents, launched a mobile Point-of-Care Ultrasound Device (POCUS) known as Venue Fit, along with the first-ever industry AI tool enabling cardiac imaging. The superior quality of the image output is anticipated to lead to accurate diagnostic results in the earliest stages of diseases. This advancement is a big step forward in treating and curing diseases that are life-threatening in nature, such as cardiovascular diseases.
The intravascular ultrasound systems market outlook is looking positive for the forecast period as governments of developing nations like India and China is adopting numerous imaging technologies, including telemedicine, to deliver cost-efficient medical imaging solutions to the end users.
Additionally, the provision of advanced catheters by intravascular ultrasound systems manufacturers, such as Philips, which offers a wide-ranging IVUS catheter portfolio for peripheral and coronary applications, is empowering physicians to better address every case. The availability of such catheters, used to provide guidance in pre-stent planning, is supporting the intravascular ultrasound systems market.
Hospitals witness the highest number and variety of ultrasound studies. Consequently, mid-and-large-sized hospitals adopt medical imaging equipment to profit from the large pool of outpatients. Therefore, the increasing utilization of ultrasound, combined with a wide patient base, is propelling the demand for intravascular ultrasound systems from hospital facilities.
Going forward, systematic reimbursement policies offered by insurers and med-tech companies are propelling the adoption of IVUS catheters. Key players in the market are tapping into new growth opportunities to further the market growth.
Among all the regions, North America is expected to continue to lead the global market for intravenous ultrasound systems over the forecast period.
Regional growth can be ascribed to certain factors, such as enhanced accessibility, the heightened adoption rate of ultrasound technology in prime care set-ups, and increased healthcare expenditure. In addition to this, the increasing incidence rate of chronic conditions and technological advancements are fueling market growth.
| Attributes | Details |
|---|---|
| Market Value (2022) | US$ 772 Million |
| Market Forecast Value (2032) | US$ 1,257.51 Million |
| Market CAGR (2022 to 2032) | 5% |
Intravascular Ultrasound Systems (IVUS) is an imaging method with which we can visualize a coronary artery from the inside out. Intravascular Ultrasound Systems are usually designed in such a way that the individual can have a complete view of the coronary artery blockade using a catheter which is attached to an ultrasound probe at one end and the other end is attached to a computerized ultrasound equipment.
The inside out view helps to find out the sent sizing, fixation, and in confirmation that the stent implanted are appropriately placed with full expansion of the stent, which fits tightly round around vessel wall. By this the cardiologist sense that the information acquired by the IVUS medium can a make a huge different in knowing how well the patients are treated and can obtain accuracy about the stent placement with reduced complications.
Now a days the IVUS diagnostic procedure is majorly used in coronary interventions where it determines and provides the qualitative information about the composition of the plaques and its echogenicity strategies. IVUS demonstrates the consistency of the plaque (soft, fibrous, calcific or mixed) and its differentiation from thrombus.
The Intravascular Ultrasound is designed with two major components i.e.
The imagining is captured by the frequency of the ultrasound which varies type of vessels which is to be scanned.
Two types of catheter systems are, one with an end-hole which are delivered over the guide wire, and those which do not have an end-hole and are introduced directly through the sheath.
The transducer design have been approached into two basic ways, i.e.
In the phased-array systems, there are multiple transducer elements (32-64) which are in arranged in an array are activated sequentially to generate the image.
Mechanical probes rotates an electric transducer at 1800 rpm, which has the capacity to produce 30 images per second.
There is drastic Increase in the number percutaneous coronary interventions and number of stent procedures. Major Lot of population now a days prefer less invasive procedures, the technological advancements in image guided therapeutic treatment and growing incidence of cardiovascular disease led to the increase in the intravascular ultrasound systems market.
The drawback for the IVUS is the high cost, lack of uniform reimbursement and threat from optical coherence tomography.
The global Intravascular Ultrasound Systems market is expected to expand at healthy CAGR owing to increasing adoption of the products across the world. Among end users, hospital end user segment is expected to account for maximum share due to requirement of advanced healthcare infrastructure and low cost.
Geographically, the global intravenous ultrasound systems market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. Among all the regions, North America will continue to lead the global market for intravenous ultrasound systems due to high purchasing power.
Asia- Pacific is expected to account for second largest share in global market primarily due to increasing number of cardiac surgeries. Regional overview can be a directly proportional to the population.
Intravascular Ultrasound Systems: Key Players
Key players operating in the global intravenous ultrasound systems market are Volcano Corporation, Boston Scientific Corporation, Terumo Corporation, Infra ReDx Inc, Philips Healthcare, Siemens Healthcare, Silicon Valley Medical Instruments Inc, and Avinger Inc.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and applications.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The global market for intravascular ultrasound systems are broadly classified on the basis of product type, applications and end user.
Explore Similar Insights
Intravascular Ultrasound Systems Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
